QUEST – Quadrivalent HPV Vaccine Evaluation Study

QUEST – Quadrivalent HPV Vaccine Evaluation Study

Project Duration: August 31, 2012 to August 30, 2013

This program is part of a national initiative (QUEST) to compare the durability and efficacy of 2 different vaccination programs against HPV in girls ages 9-12. Participants are enrolled across Canada. Vaccine is given as either 2-doses or 3-doses as part of a larger clinical trial. Participants are followed until age 19 or 120 months after the first dose of vaccine. Endpoints include assessment of type specific persistent HPV infection from self-collected vaginal specimens and serum, and monitoring the antibody in the two different vaccination groups

For more updates subscribe to our monthly newsletter or follow us on social media!
NEWSLETTER

No Comments

Add your comment